SAN FRANCISCO, Calif. – September 21, 2007 – Synarc Inc., the world's leading provider of medical imaging analysis, biochemical marker, and subject recruitment services to the pharmaceutical and biotechnology industries, today announced the appointment of Luisa Contreiras to senior vice president and chief technology officer.
Prior to joining Synarc, Contreiras served as Vice President, Technology & Operations at Gentiae Clinical Research. Previously, as chief technology officer at Concuity, she developed web-based solutions to automate and streamline complex healthcare financial processes including data operations.
“One of Synarc's competitive advantages is developing and supporting market-leading technology," said Gary Velasquez, chief executive officer of Synarc. "I am confident that Luisa’s expertise and leadership in this area will complement our world-class service to our customers."
Contreiras holds a degree in Physics from Massachusetts Institute of Technology. She has consulted and spoken extensively on the topic of technology in healthcare and healthcare on the Internet.
Synarc was formed in 1998 and since then has contributed to the approval of more leading compounds, across a broad spectrum of therapeutic areas, than any other central imaging provider.
About Synarc
Synarc’s medical image analysis, biochemical marker and clinical research center services enable life-science industry clients to execute clinical trials accurately while decreasing the time, uncertainty, and cost of product development. Synarc has partnered with industry leaders to bring numerous leading compounds to market across a broad spectrum of therapeutic areas. Our services integrate critical aspects of clinical-trial design and execution, from protocol design and subject recruitment to regulatory liaison on behalf of our clients. Our expert radiologists and scientists are innovators in all aspects of medical image analysis and biochemical markers in drug development, and have pioneered many methods used in todays clinical trials. Synarc has seventeen offices around the world. Synarc's medical image analysis, biochemical marker and clinical research center services are currently used in more than 200 clinical trials around the world.
